PTEN and breast cancer: Notably, 67% of Pten hypermorphic mice (Ptenhy/+), expressing 80% of normal levels of PTEN, develop sporadic mammary tumours, indicating that even subtle reductions in PTEN levels can predispose to mammary tumourigenesis [46].